Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's sovereign wealth fund. Upon regulatory approval in India, the RDIF shall supply to Dr Reddy’s 100...
Equity benchmark indices traded higher in the afternoon session on September 16 while Asian stocks were flat ahead of the US Federal Reserve's view on the economy. The BSE S-P Sensex closed 259 points or 0.66 per cent at 39,303 while the Nifty 50 gained by 83 points or 0.72 per cent at 11,605. Except for Nifty media and PSU bank, all sectoral indices at the National Stock Exchange were in the positive zone with Nifty realty gaining by 2.2 per cent, pharma by 2 per cent and auto by 1.5 per cent. Among stocks, Dr Reddy's jumped by 4.44 per cent to close at Rs 4,639.60 per share after it announced cooperation with Russian Direct Investment Fund (RDIF) to conduct clinical trials and distribute Sputnik V vaccine in India for treatment of COVID-19. Mahindra - Mahindra accelerated by 4 per cent to Rs 638.05 per share while Bajaj Auto moved up by 3.5 per cent and Tata Motors by 1.7 per cent.
India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said on Tuesday. "The government of India attaches great importance to this offer of partnership from a friend," said V. K. Paul, member of NITI Aayog.
Credit: HT Digital Content Duration: 03:32Published
Equity benchmark indices were down on September 30. At 10:00 am, the BSE was down by 95 points or 0.25 per cent and was trading at 37,876, while Nifty was trading also dipped by 7 points or -0.06 per cent at 11,215. The top gainers in the BSE include Sun Pharma, HUL and Asian Paints. SunPharma was trading up with shares at Rs 512 points up by 1.57 per cent, HUL was at Rs 2,055 and Asian Paints at Rs 1,979. Top gainers at NSE included CIPLA, Dr Reddy and Divi's Laboratories Limited. CIPLA was trading at Rs 789 up by 3.49 per cent, Dr Reddy at Rs 5,225 up by 2.77 per cent and Divi's Laboratories Limited was trading at Rs 3,119.
Equity benchmark indices traded higher during early hours on Friday amid mixed cues from their Asian peers. At 10:15 am, the BSE S-P Sensex was up by 136 points or 0.35 per cent at 39,115 while the Nifty 50 moved up by 56 points or 0.48 per cent at 11,576. Except for Nifty FMCG, all sectoral indices at the National Stock Exchange were in the green with Nifty pharma gaining by 3.8 per cent, realty by 0.9 per cent and auto by 0.7 per cent. Among stocks, Dr Reddy's Laboratories jumped by 4.6 per cent to Rs 5,051.20 per share after the company said it has settled its patent litigation with Celgene for the latter's cancer drug capsules. Cipla ticked up by 5.4 per cent and Sun Pharma by 3 per cent while Oberoi Realty advanced by 2.4 per cent. Eicher Motors, Adani Ports, Tech Mahindra and Wirpo traded with a positive bias. FMCG stocks fell with Hindustan Uniliver slipping by 1.4 per cent, Nestle India by 0.3 per cent and Britannia by 0.2 per cent.
Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3 trial of the vaccine candidate. Bharat Biotech is working with the Indian Council of Medical Research (ICMR) to develop a vaccine candidate – Covaxin. The pharma company recently signed an agreement with the Washington University School of Medicine for an intranasal single-dose vaccine. Watch the full video for more details.
Credit: HT Digital Content Duration: 02:29Published
Shreyas Iyer-led Delhi Capitals left the hotel in Dubai to lock horns with Sunrisers Hyderabad on September 29. With two straight wins, Delhi Capitals is on the top of the table while Hyderabad is at the bottom. Both the teams will battle for the win in Abu Dhabi.
Union MoS for Home G Kishan Reddy and Minister of Municipal Administration and Urban Development KT Rama Rao inaugurated the span concrete deck extra-dosed cable-stayed bridge at Durgam Cheruvu of Hyderabad on September 25. Built by Larsen and Toubro, the bridge is expected to ease traffic flow towards HITEC City. It will also reduce commute time from Jubilee Hills to Madhapur from 30 to 10 minutes and the distance from Mind Space to Jubilee Hills by 2 kms. As per media reports, this bridge was constructed at the cost of Rs 184 crore.
Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on... IndiaTimes Also reported by •Hindu •Mid-Day •DNA